Impact of ND0612 on Levodopa-Induced Dyskinesia in Parkinson’s Disease: Post hoc Analyses From a Randomized, Active-Controlled Study
Objective: To evaluate dyskinesia-related outcomes between optimized subcutaneously administered levodopa/carbidopa (ND0612) + immediate-release levodopa/carbidopa (IR-LD/CD) vs optimized oral IR-LD/CD in patients with Parkinson’s disease (PD).…Effect of Virtual Rehabilitation Therapy on Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis
Objective: To assess the efficacy of virtual rehabilitation therapy compared to conventional physical therapy in patients with Parkinson’s disease. Background: Rehabilitation is essential in managing…A Novel Quantitative Assessment to Evaluate Functional Impairment in Parkinson’s Disease
Objective: To investigate if motion data collected from inertial measurement units (IMUs) mounted on implements used in activities of daily living (ADLs) can characterize the…Opicapone in Parkinson’s Patients with Probable REM Sleep Behavior Disorder: Insights from the OASIS Trial
Objective: To evaluate opicapone’s effect on sleep disturbances, motor and non-motor symptoms and quality of life in Parkinson's disease (PD) patients with and without probable…Validation of a quantitative test using kinesiological evaluation of upper extremity movements in patients with Parkinson’s disease: A pilot study.
Objective: To establish the validity of an upper extremity kinesiological assessment in patients with Parkinson's disease as a complementary tool to clinical instruments. Background: Parkinson's…Embodying a Sixth Soft Finger. How Wearing a Supernumerary Robotic Digit Impacts our Body Schema
Objective: To assess whether a supernumerary robotic digit can enter into the user’s body schema, thereby altering bodily self-representation and proprioceptive awareness. Background: Stroke is…Changes in Motor States Throughout the Waking Day With Tavapadon in People With Parkinson’s Disease
Objective: To evaluate motor states throughout the waking day when adding tavapadon to oral carbidopa/levodopa in adults with Parkinson’s disease experiencing motor fluctuations. Background: Long-term…Study on individual differences in shoulder and hip joints during walking in patients with Parkinson’s disease
Objective: To analyze the motion characteristics of the shoulder and hip joints during gait in people with Parkinson’s disease (PwP) and explore the classification of…Advancing Hypomimia Assessment in Parkinson’s Disease by Integrating a Continuous Monitoring Device into Clinical Practice
Objective: We aim to establish a robust, continuous method for monitoring hypomimia in Parkinson’s disease (PD), bridging the gap between sporadic clinical evaluations and real-life…Heat Map Visualization of Improved Best ON Time in People With Parkinson’s Disease Treated With Foscarbidopa/Foslevodopa
Objective: Assess the impact of foscarbidopa/foslevodopa (CDp/LDp) continuous subcutaneous infusion (CSCI) on the motor states of people with Parkinson’s disease (PD) across 24 hours via…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 40
- Next Page »
